Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Terapevticheskii Arkhiv|May 31, 2013
[Ibuprofen: safety and efficiency of its use in wide clinical practice]T E Morozova, T B Andrushchishina, E K AntipovaKlinicheskaia Meditsina|January 1, 1995
[Effectiveness and tolerance of benazepril versus captopril in patients with hypertension]L I Ol'binskaia, S A Golubev, T E MorozovaKardiologiia|November 26, 2010
[An experience of the use of angiotensin II receptor blocker losartan in patients with metabolic syndrome and chronic kidney disease]A V Beloborodova, T E Morozova, E M ShilovKardiologiia|August 2, 2003
[Blood pressure 24-hour rhythms and variability in adolescents with hypertension]L I Ol'binskaia, T E Morozova, E V LadonkinaEksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|January 29, 2016
[NSAID GASTROPATHY IN PATIENTS WITH COMORBID DISEASES]T E Morozova, S M Rykova, M A ChukinaTerapevticheskii Arkhiv|December 19, 2014
[Principles of choice of an angiotensin-converting enzyme inhibitor: specific features of perindopril]T E Morozova, S V Gontarenko, E P Kuz'minaTerapevticheskii Arkhiv|January 30, 2016
[Chronic obstructive pulmonary disease concurrent with hypertension: Evaluation of the therapeutic effect of prolonged-release indapamide]S I Ovcharenko, T E Morozova, Z N NersesyanKardiologiia|July 20, 2019
[In-hospital Myocardial Infarction: Scale of the Problem]Yu V Lykov, N V Dyatlov, T E Morozova, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 5, 2026
[Clinical features of chronic pain and premorbid factors in patients with various phenotypes of metabolic syndrome]O V Vorob'eva, A A Gertsog, G M Ashikhmin, et al.Biomeditsinskaia Khimiia|October 30, 2017
[Pharmacogenetic approaches to predicting the efficiency and safety of amlodipine in patients with arterial hypertension]D A Sychev, N V Shih, E G Kalle, et al.Pageof 3